1. Home
  2. STRO vs LGO Comparison

STRO vs LGO Comparison

Compare STRO & LGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • STRO
  • LGO
  • Stock Information
  • Founded
  • STRO 2003
  • LGO 1988
  • Country
  • STRO United States
  • LGO Canada
  • Employees
  • STRO N/A
  • LGO N/A
  • Industry
  • STRO Biotechnology: Biological Products (No Diagnostic Substances)
  • LGO
  • Sector
  • STRO Health Care
  • LGO
  • Exchange
  • STRO Nasdaq
  • LGO Nasdaq
  • Market Cap
  • STRO 77.7M
  • LGO 91.0M
  • IPO Year
  • STRO 2018
  • LGO 2007
  • Fundamental
  • Price
  • STRO $0.88
  • LGO $1.40
  • Analyst Decision
  • STRO Hold
  • LGO Strong Buy
  • Analyst Count
  • STRO 7
  • LGO 1
  • Target Price
  • STRO $3.97
  • LGO $3.70
  • AVG Volume (30 Days)
  • STRO 513.9K
  • LGO 208.5K
  • Earning Date
  • STRO 08-12-2025
  • LGO 08-07-2025
  • Dividend Yield
  • STRO N/A
  • LGO N/A
  • EPS Growth
  • STRO N/A
  • LGO N/A
  • EPS
  • STRO N/A
  • LGO N/A
  • Revenue
  • STRO $66,434,000.00
  • LGO $110,968,000.00
  • Revenue This Year
  • STRO N/A
  • LGO $23.62
  • Revenue Next Year
  • STRO N/A
  • LGO $41.27
  • P/E Ratio
  • STRO N/A
  • LGO N/A
  • Revenue Growth
  • STRO N/A
  • LGO N/A
  • 52 Week Low
  • STRO $0.52
  • LGO $1.12
  • 52 Week High
  • STRO $5.17
  • LGO $2.84
  • Technical
  • Relative Strength Index (RSI)
  • STRO 57.66
  • LGO 46.82
  • Support Level
  • STRO $0.83
  • LGO $1.40
  • Resistance Level
  • STRO $1.01
  • LGO $1.68
  • Average True Range (ATR)
  • STRO 0.07
  • LGO 0.13
  • MACD
  • STRO 0.01
  • LGO -0.01
  • Stochastic Oscillator
  • STRO 51.67
  • LGO 16.36

About STRO Sutro Biopharma Inc.

Sutro Biopharma Inc is a clinical-stage drug discovery, development, and manufacturing company. It is mainly engaged in the development of biopharmaceutical products. The company manufactures next-generation protein therapeutics for cancer and autoimmune disorders through its proprietary integrated cell-free protein synthesis platform, XpressCF. Products offered by the company include STRO-001 for patients with multiple myeloma and non-Hodgkin lymphoma and STRO-002 for the treatment of ovarian and endometrial cancers. The company also pipeline contains STRO-004, STRO-006, STRO-00X, STRO-00Y, STRO-003, VAX24, VAX31, and Others.

About LGO Largo Inc.

Largo Inc is committed to the production and supply of high-quality vanadium products. The company is also focused on the advancement of renewable energy storage solutions through Largo Clean Energy and its vanadium redox flow battery technology. The Company is engaged in the mining, exploration, and development of mineral properties, predominantly in Brazil, through which it produces and supplies vanadium products VPURE Flake, VPURE+ Flake, and VPURE+ Powder. The company has operating segments: sales & trading, mine properties, which generates key revenue, corporate, exploration and evaluation properties, Clean Energy, and Largo Physical Vanadium.

Share on Social Networks: